Mental ID is a Europe-based startup focused on addressing the Mental Health Crisis and Chronic Diseases expansion. Founded in 2019, the company boasts an inclusive, international team and an ambitious expansion plan. Their flagship product, Ilona, is an intelligent platform offering holistic patient profiling and risk analytics solutions. Mental ID's innovative approach aims to alleviate the burden on healthcare professionals by providing comprehensive psychological, behavioral, and psychosomatic patient profiles before their initial appointment. This not only optimizes the time dedicated to the first meeting but also enables personalized, fast-track treatment. The company's commitment to delivering safe, accurate, and precise outcomes strengthens patient-doctor relationships.
Although specific details such as investment amount, investors, and current industries are not available, Mental ID's dedication to revolutionizing mental healthcare through technology and data-driven solutions shows great promise. With its headquarters in Spain, Mental ID's vision and product offerings position it as a valuable player in the evolving landscape of healthcare technology. For potential investors looking to support innovative solutions in mental healthcare, collaborating with Mental ID could offer lucrative opportunities for growth and positive societal impact.
There is no investment information
No recent news or press coverage available for MENTAL ID.